Previous 10 | Next 10 |
2024-06-18 14:13:37 ET More on Pfizer Pfizer Stock: The Reversal Should Keep Going Pfizer: Headwinds Dissipating, New Obesity Pipeline Update Coming Soon Pfizer Inc. (PFE) CEO Albert Bourla presents at Goldman Sachs 45th Annual Global Healthcare Conference (Transcrip...
2024-06-17 11:17:09 ET More on BioNTech BioNTech: Managements Wants 10 Oncology Drug Approvals By 2030, I'm Skeptical BioNTech SE 2024 Q1 - Results - Earnings Call Presentation BioNTech SE (BNTX) Q1 2024 Earnings Call Transcript FDA recommends KP.2 strain be ...
2024-06-13 18:34:04 ET More on BioNTech, Moderna, etc. BioNTech: Managements Wants 10 Oncology Drug Approvals By 2030, I'm Skeptical Pfizer: Headwinds Dissipating, New Obesity Pipeline Update Coming Soon Moderna, Inc. (MRNA) Goldman Sachs 45th Annual Global Healthcar...
2024-06-13 17:48:39 ET Summary BioNTech's revenue soared during the COVID era, but the company faces uncertainty with declining vaccine sales and plans for new oncology-focused products. The company is shifting focus to oncology programs, aiming for multiple late-stage trials and ...
2024-06-11 21:30:00 ET Summary We purchased Maravai shares early in Q3 2023, increased position as stock price dropped, similar to experience with META in 2022. Maravai's subsidiaries, TriLink and Cygnus, play critical roles in NAP and BS segments, with unique assets and capabilit...
2024-06-07 12:11:30 ET More on BioNTech, Moderna, etc. Pfizer: Surging Cancer Rates Will Boost Revenues Moderna, Inc. (MRNA) Jefferies 2024 Global Healthcare Conference (Transcript) Pfizer: Too Early For A Turnaround Moderna mRNA candidate chosen for FDA rare...
2024-06-06 08:04:56 ET More on Sanofi, Novavax, etc. Novavax: Sanofi Partnership Revitalizes My Magnum Opus Novavax, Inc. (NVAX) Q1 2024 Earnings Call Transcript Novavax Ditches 'Going Concern,' Embraces Sanofi Safety Net (Rating Upgrade) Bird flu death in Me...
2024-06-05 16:30:31 ET More on vaccine makers Pfizer: The Chart Looks Like A Bottom, But Is The Dividend Safe? COVID vaccine makers ready updated shots for fall immunization drive Pfizer data for breast cancer therapy sends Olema higher Moderna, Inc. (MRNA) M...
2024-06-05 10:52:27 ET More on BioNTech, Moderna, etc. Moderna, Inc. (MRNA) Moderna Oncology Investor Event (Transcript) Moderna, Inc. (MRNA) Bernstein's 40th Annual Strategic Decisions Conference (Transcript) Pfizer: The Chart Looks Like A Bottom, But Is The Dividen...
2024-06-02 03:00:00 ET Summary Suzhou MediLink partners with BioNTech to use its antibody-drug conjugate platform, receiving an upfront payment of $25 million and up to $1.8 billion in milestones. Asahi Kasei offers $1.1 billion to acquire Calliditas Therapeutics, aiming to expand...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...
The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Recommendation is based on pre-clinical and epidemiological data showing that the JN.1-adapted monovalent COVID-19 vaccine generates an improved ...